Toll-like receptors in multiple sclerosis mouse experimental models

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 458-462

  Marta, Monica ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

EAE; Multiple sclerosis; MyD88; TLR

Indexed keywords

BETA INTERFERON; FREUND ADJUVANT; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ALLERGIC ENCEPHALOMYELITIS; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONFERENCE PAPER; DENDRITIC CELL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MULTIPLE SCLEROSIS; NONHUMAN; SIGNAL TRANSDUCTION; TH17 CELL;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 69949184869     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04849.x     Document Type: Conference Paper

References (30)

1. Creagh, E.M. & L.A. O'Neill. 2006. TLRs, NLRs and RLRs: a trinity of pathogen sensors that cooperate in innate immunity. Trends Immunol. 27: 352-357.
2. Akira, S. & H. Hemmi. 2003. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85: 85-95.
3. Medzhitov, R. & C.A. Janeway, Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296: 298-300.
4. Smiley, S.T., J.A. King & W.W. Hancock. 2001. Fib-rinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 167: 2887-2894.
5. Biragyn, A. et al. 2002. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298: 1025-1029.
6. Kariko, K. et al. 2004. mRNA is an endogenous lig-and for Toll-like receptor 3. J. Biol. Chem. 279: 12542-12550.
7. Leadbetter, E.A. et al. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
8. Ronnblom, L. & G.V. Alm. 2003. Systemic lupus ery-thematosus and the type I interferon system. Arthritis Res. Ther. 5: 68-75.
9. Takeda, K., T. Kaisho & S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376.
10. Kabelitz, D. 2007. Expression and function of tolllike receptors in T lymphocytes. Curr. Opin. Immunol. 19: 39-45.
11. Bsibsi, M. et al. 2002. Broad expression of toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61: 1013-1021.
12. Hurst, J. & P. von Landenberg. 2008. Toll-like receptors and autoimmunity. Autoimmun. Rev. 7: 204-208.
13. Pisetsky, D.S. 2008. The role of innate immunity in the induction of autoimmunity. Autoimmun. Rev. 8: 69-72.
14. Baker, D. et al. 1990. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J. Neuroimmunol. 28: 261-270.
15. Lorentzen, J.C. et al. 1995. Protracted, relapsing and demyelinating experimental autoimmune en-cephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant. J. N e u-roimmunol. 63: 193-205.
16. Stromnes, I.M. et al. 2008. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 14: 337-342.
17. Prinz, M. et al. 2006. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 116: 456-464.
18. Lampropoulou, V. et al. 2008. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 180: 4763-4773.
19. Kerfoot, S.M. et al. 2004. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J. Immunol. 173: 7070-7077.
20. Marta, M. et al. 2008. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Eur. J. Immunol. 38: 565-575.
21. Touil, T. et al. 2006. Cutting edge: TLR3 stimulation suppresses experimental autoimmune en-cephalomyelitis by inducing endogenous IFN-beta. J. Immunol. 177: 7505-7509.
22. Andersson, A. et al. 2008. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J. Leukoc. Biol. 84: 1248-1255.
23. Jack, C.S. et al. 2007. Th1 polarization of CD4+ T cells by toll-like receptor 3-activated human mi-croglia. J. Neuropathol. Exp. Neurol. 66: 848-859.
24. Tasaki, K. et al. 1997. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748: 267-270.
25. Medvedev, A.E. et al. 2002. Dysregulation of LPS-induced toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J. Immunol. 169: 5209-5216.
26. Glezer, I., A. Lapointe & S. Rivest. 2006. Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FA S E B J. 20: 750-752.
27. Kim, W.U., A. Sreih & R. Bucala. 2009. Toll-like receptors in systemic lupus erythematosus prospects for therapeutic intervention. Autoimmun. Rev. 8: 204-208.
28. Lundberg, A.M. et al. 2007. Key differences in TLR3/poly I: C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. Blood 110: 3245-3252.
29. Honda, K. et al. 2005. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434: 1035-1040.
30. Hornung, V. et al. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537.